Phase 4 Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with rheumatoid arthritis (RA) based on recognised international medical guidelines (EULAR/ACR 2010 criteria)
- People whose RA is considered moderately to highly active, based on a standard disease activity score (DAS28-CRP above 3.2)
- People whose RA has not responded well enough to the medicine methotrexate (taken weekly at 15mg or more for at least 3 months), or to leflunomide (taken daily for at least 3 months)
- People who have joint damage visible on X-ray and/or specific blood markers associated with RA (rheumatoid factor and/or anti-CCP antibodies)
- People aged 18 years or older
- People who have read, understood, and signed a written consent form before any trial procedures begin
- People who are enrolled in a social insurance system
- Women who could potentially become pregnant must have a negative pregnancy test (β-HCG) before joining
- Women who could potentially become pregnant must agree to use an effective method of contraception throughout the trial and for a period after it ends (the required duration depends on which medicine is used — confirm with trial site)
Who may not be able to join:
- People who have previously been treated with, or who have a medical reason preventing the use of, targeted therapies such as biologics or JAK/STAT inhibitors
- People who have previously received "triple therapy" (a combination of three specific RA medicines — confirm with trial site)
- People who have another type of inflammatory joint condition in addition to RA, except for RA combined with Sjögren's syndrome
- People who have medical reasons preventing the use of all biologics, JAK/STAT inhibitors, or all of the following medicines: methotrexate, leflunomide, sulfasalazine, and hydroxychloroquine
- People who have been taking corticosteroids (such as prednisone) at a dose higher than 15mg per day for at least 4 weeks before joining the trial
- People who have not been screened for tuberculosis
- People who would not be able to attend follow-up appointments over 12 months
- People who are pregnant, breastfeeding, or planning to become pregnant within the next 12 months
- People with a current dependency on drugs or alcohol
- People who have taken part in another clinical trial involving an investigational medicine within the 4 weeks before this trial's treatment begins
- Women who could potentially become pregnant and are not using an effective form of contraception
- People who are under legal protection orders (confirm with trial site)
- People who are currently imprisoned
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 3 88 12 79 53
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Numbers of participant with low disease activity (DAS28-CRP<3.2) and a daily dose ≤ 7.5 mg/day of equivalent prednisone
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.